News

RFK Jr. Appoints Vaccine Critics To CDC Vaccine Panel After Firing Entire Advisory Committee: Report
Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC's Advisory Committee on Immunization Practices.
Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript
Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 2:00 PM ETCompany ParticipantsJames Patrick Kelly ...
Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents
It is unclear how new members of the panel have been vetted for conflicts of interest. Read more at straitstimes.com. Read ...
Novavax (NasdaqGS:NVAX) Announces Promising Results for New Vaccine Candidates
Novavax (NasdaqGS:NVAX) recently reported initial results from its Phase 3 trial for its COVID-19-Influenza Combination and seasonal influenza vaccines, which showed immune responses comparable to ...
Fierce Biotech16h
FDA aims for 'rapid or instant' drug reviews, with AI tool initially assessing applications
The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...
Novavax's Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Phase 3 Trial
Novavax's combo and standalone flu vaccines showed strong immune responses and good safety in a Phase 3 trial of adults 65 ...
Kennedy Pledges to Immediately Replace Vaccine Advisors, Shortcutting Vetting Process
There are two weeks to go until the panel’s next scheduled meeting. As of Wednesday morning, the committee has no known ...
UK Trial Over Covid Contract Awarded to Tory Peer-Linked Firm Begins
A contract awarded by the UK during the pandemic to a firm linked to a Tory peer came under court scrutiny as government ...
Stocktwits on MSN20h
Novavax’s Covid-Flu Combo, Standalone Flu Vaccines Demonstrate Robust Immune Response In Late-Stage Trial: Retail Says It’s ‘A Very Good Sign’
Novavax, Inc. (NVAX) on Wednesday said that its COVID-19-Influenza combination and stand-alone Influenza vaccine candidates ...
Novavax's COVID-flu combo vaccine shows strong immune response in trial
Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines showed strong immune responses in ...
Novavax posts immune data to back COVID-flu combo shot and standalone flu shot
Novavax (NVAX) stock gains as the company reports promising Phase 3 trial results for its COVID-19-Influenza combo vaccine and stand-alone flu shot. Read more here.